台灣地區異位性皮膚炎病患之健保門診藥費

Drug Costs of Outpatients with Atopic Dermatitis under National Health Insurance in Taiwan

10.29539/CNABH.200912.0013

鍾麗琴(Li-Ching Chung)；陳怡君(Yi-Chun Chen)；謝明娟(Ming-Chuan Hsieh)

異位性皮膚炎 ； 藥費 ； 門診 ； Atopic dermatitis ； Drug cost ； Outpatient

嘉南學報（人文類）

35期（2009 / 12 / 01）

523 - 530

繁體中文

本研究在探討2004年台灣地區異位性皮膚炎門診病患的藥品費用。研究樣本來自全民健康保險資料庫之承保抽樣歸人檔，共二十萬人爲基礎，篩選國際疾病診斷分類第九版臨床修正版(ICD-9-CM)診斷碼691.8和692.9之異位性皮膚炎患者門診次數，以統計分析軟體SPSS進行健保各分區異位性皮膚炎門診病患的整體描述性統計分析。研究之主要結果如下：台灣地區2004年異位性皮膚炎病患的平均每人次門診藥費爲201.2元，每人次門診給藥日數與給藥藥品筆數分別爲6.4天與2.9筆。異位性皮膚炎男性病患的藥費、給藥日數與給藥藥品筆數高於女性病患，年齡愈大者其藥費、給藥日數與藥品筆數愈多。大致而言醫學中心的藥費與給藥日數較多，但在健保東區分局地區醫院申報的藥費與給藥日數較多。

The purpose of this research was to explore the cost of drug of outpatients with atopic dermatitis in Taiwan in 2004. A nationwide data extracted from National Health Insurance Research Databases were analyzed. The visits of outpatients with atopic dermatitis coded by ICD-9-CM as 691.8 and 692.9 were screening for analysis with software programs of SPSS. The results showed that the average drug cost per outpatient's visit was 201.2NT dollars, the average drug delivery days per prescription were 6.4 days and there were average 2.9 kinds of drug in each prescription. The drug cost are higher in the elder or male patients with atopic dermatitis. When patients were males or elder, the clinic physician gave them more kinds of drug and drug delivery days than females or young people. Generally, the drug delivery days and claimed cost of drug of outpatients were the highest in the medical centers, but in the eastern Taiwan, they happened in the community hospitals.

1. 文羽苹、江東亮(2002)。全民健康保險學術資料庫基本檔的應用經驗。臺灣衛誌，21，150-155。
   連結：
2. 羅健銘、陳素秋、賴允亮(2007)。住院癌末病患照護型態對住院醫療費用與住院天數之影響。臺灣衛誌，26(4)，270-282。
   連結：
3. (2003).National Institute of Arthritis and Musculoskeletal and Skin Diseases: Handout on health: atopic dermatitis. U.S. Department of Health and Human Services
4. Asher, M.,Montefort, S.,Bjorksten, B.(2006).Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema in childhood.ISAAC Phases One and Three Repeat Multicountry Cross-sectional Surveys. The Lancet,368,733-743.
5. Barbeau, M.,Bpharm, E. L.(2006).Burden of atopie dermatitis in Canada.International Journal of Dermatology,45,31-36.
6. Chen, G. Y.,Cheng, Y. W.,Wang, C. Y(2008).Prevalence of skin disease among schoolchildren in Magong, Penghu, Taiwan: A community-based clinical survey.Journal of the Formosan Medical Association,107,21-29.
7. Ellis, C. N.,Drake, L. A.,Prendergast, M. M.(2002).Cost of atopic dermatitis and eczema in the United States.Journal of the American Academy of Dermatology,46,361-370.
8. Fivenson, D.,Arnold, R. J.,Kaniecki, D. J.(2002).The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a laige managed care oiganization.The American Journal of Managed Care: Pharmacy Benefits Management,8,333-342.
9. Kapoor. R.,Ivlenon. C.,Hoffstad O.(2008).The prevalence of atopic triad in children with physician-confirmed atopic dermatitis.Journal of the American Academy of Dermatology,58,68-73.
10. Paller, A. S.,McAlister. R. O.,Doyle, J. J.,Jackson, A.(2002).Perceptions of physicians and pediatric patients about atopie dermatitis, its impact and its treatment.Clinical Pediatrics,41,323-332.
11. Ricci, G.,Bendandi, B.,Pagliara, L.,Patrizi, A.,Masi, M.(2006).Atopic derniatitis in Italian Children Evaluation of Its Economic Impact.Journal of Pediatric Health Care,20(5),311-315.
12. Spergel, J. M.,Paller, A. S.(2003).Atopic dermatitis and the atopic march.The Journal of Allergy and Clinical Immunology,112(6),118-127.
13. Su, J. C.,Kemp, A. S.,Varigos, G. A.,Nolan, T. M.(1997).Atopic eczema: its impact on the family and financial cost.Archives of Disease in Childhood,76,159-162.
14. Verboom, P.,Roijen, LH-V.,Sturkenboom, M.(2002).Epidemiology and health services research the cost of atopic dermatitis in the Netherlands: An international comparison.British Journal of Dermatology,147,716-724.
15. Yan, D. C.,Ou, L. S.,Tsai, T. L.(2005).Prevalence and severity of symptoms of asthma, rhinitis, and eczema in 13-to 14-year-old children m Taipei, Taiwan.Annals of Allergy, Asthma and Immunology,95,579-585.
16. 于鴻仁、楊崑德(2004)。異位性皮膚炎的致病性與防治現況。臺灣兒科醫學會，45，11-23。
17. 吳克恭(2000)。異位性皮膚炎。臺灣兒童過敏娜耑及免疫學會學會通訊，1(3)，3-6。
18. 高美英、吳齊殷(2002)。行政院衛生署科技發展計畫行政院衛生署科技發展計畫,未出版
19. 許育彰、黃文鴻、鄭守夏(2003)。門診非成癮性止痛藥之處方型態。臺灣醫學，7(6)，850-859。
20. 楊佳懿、王莉芳(1999)。異位性皮膚炎。臺灣醫學，3(4)，423-429。
21. 鍾麗琴、陳惠芳(2008)。南區參與家庭醫師整合試辦計畫診所病人用藥行為之研究。健康保險，4(2)，48-68。
22. 顧明修、呂克桓(2004)。異位性皮膚炎。臺灣兒童過敏氣喘及免疫學會學會通訊，5(1)，10-11。